Categories: ActiveEngineeringFinTechInformationJobMediaPersonalRecruitingSecuritySocial
Vittoria Biotherapeutics is committed to unlocking the promise of cell therapies while addressing their inherent challenges by strengthening efficacy, improving safety, and broadening therapeutic applicability for patients with difficult-to-treat diseases. An Important Note About Privacy: Vittoria Biotherapeutics is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth, or bank account details via email, job recruiting, or social media platforms. We do not hire virtually or solicit/interview candidates on Indeed, Telegram, Wire, Google Hangouts or similar public platforms. Any questions about career opportunities can be directed to info@vittoriabio.com.
Investors 2
Mentions in press and media 6
| Date | Title | Description |
| 12.11.2024 | Vittoria Biotherapeutics Completes $25 Million In Private Financing To Propel Groundbreaking Cell Therapy Candidates | PHILADELPHIA, Nov. 12, 2024 (GLOBE NEWSWIRE) — Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company specializing in the development of innovative cell therapies for hard-to-treat diseases, today announced the successful co... |
| 12.11.2024 | Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates | Funding to support clinical proof-of-concept for the lead program, VIPER-101
PHILADELPHIA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company specializing in the development of innovativ... |
| 12.11.2024 | Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates | Funding to support clinical proof-of-concept for the lead program, VIPER-101
PHILADELPHIA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company specializing in the development of innovativ... |
| 20.12.2023 | Philly Money Moves: Biotech firm Vivodyne raised $38M for lab-grown organ development | Money Moves is a column where we chart the raises, mergers and other funding news of tech companies across the region on the third Wednesday of the month. Have a tip? Email us at philly@technical.ly.
Update: Mention of PolicyMap's Series A ... |
| 14.11.2023 | Vittoria Biotherapeutics Secures Over $15 Million in Private Financing Round to Support the Development of Novel CAR-T Cell Therapies | - |
| - | Vittoria Biotherapeutics | “Pioneering the Next Generation of Cell Therapies Reimagining T cell engineering A therapeutic pipeline targeting unmet clinical needs About Senza5™ Technology Cell Therapy “3.0” Company with Clinical Stage Lead Program CELL THERAPY “3.0” T... |
Reviews 0
